Accelerate Diagnostics, Inc.
AXDX
$0.9401
-$0.0018-0.19%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -5.43% | -8.52% | -12.19% | 3.14% | 8.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.43% | -8.52% | -12.19% | 3.14% | 8.23% |
| Cost of Revenue | 0.63% | -33.86% | -38.58% | -28.38% | -22.31% |
| Gross Profit | -22.77% | 421.82% | 817.78% | 836.06% | 964.40% |
| SG&A Expenses | -20.33% | -18.40% | -21.97% | -15.82% | -20.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.53% | -14.89% | -14.65% | -5.11% | -9.34% |
| Operating Income | 13.98% | 16.12% | 15.13% | 6.61% | 12.24% |
| Income Before Tax | 2.88% | 10.79% | -25.46% | 1.47% | 19.43% |
| Income Tax Expenses | 1,205.19% | 366.67% | 75.56% | -271.11% | -271.11% |
| Earnings from Continuing Operations | 1.40% | 10.55% | -25.49% | 1.65% | 19.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.40% | 10.55% | -25.49% | 1.65% | 19.57% |
| EBIT | 13.98% | 16.12% | 15.13% | 6.61% | 12.24% |
| EBITDA | 15.10% | 17.39% | 16.49% | 7.96% | 13.38% |
| EPS Basic | 28.83% | 36.87% | 14.20% | 28.60% | 38.59% |
| Normalized Basic EPS | 39.15% | 43.79% | 44.36% | 40.15% | 41.71% |
| EPS Diluted | 28.85% | 36.82% | 14.13% | 28.53% | 38.54% |
| Normalized Diluted EPS | 39.26% | 43.88% | 44.36% | 40.15% | 41.71% |
| Average Basic Shares Outstanding | 51.75% | 51.50% | 44.82% | 40.18% | 33.05% |
| Average Diluted Shares Outstanding | 52.12% | 51.91% | 44.82% | 40.18% | 33.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
